Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators

Guowei Ma, Chuang Yang, Yonggang Chen, Ji Luo, Xiang Zhu, Jie Chen

Open source

DOI
10.7717/peerj.21911
Published
2026-10-30
Container
PeerJ
Publisher
PeerJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7717/peerj.21911,
  title = {Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators},
  author = {Guowei Ma and Chuang Yang and Yonggang Chen and Ji Luo and Xiang Zhu and Jie Chen},
  year = {2026},
  journal = {PeerJ},
  doi = {10.7717/peerj.21911},
  url = {https://doi.org/10.7717/peerj.21911}
}

RIS

TY  - JOUR
TI  - Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators
AU  - Guowei Ma
AU  - Chuang Yang
AU  - Yonggang Chen
AU  - Ji Luo
AU  - Xiang Zhu
AU  - Jie Chen
PY  - 2026
JO  - PeerJ
DO  - 10.7717/peerj.21911
UR  - https://doi.org/10.7717/peerj.21911
ER  - 

APA

Ma, G., Yang, C., Chen, Y., Luo, J., Zhu, X., & Chen, J. (2026). Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators. PeerJ. https://doi.org/10.7717/peerj.21911

Source records